Literature DB >> 10675403

Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakaryocytic colony formation in vitro.

H Isomura1, M Yoshida, H Namba, N Fujiwara, R Ohuchi, F Uno, M Oda, Y Seino, M Yamada.   

Abstract

Two clinical observations, the association of human herpesvirus-6 (HHV-6) with delayed engraftment after stem cell transplantation and thrombocytopenia concomitant with exanthema subitum, prompted us to evaluate the suppressive effects of HHV-6 on thrombopoiesis in vitro. Different culture conditions for thrombopoietin (TPO)-inducible colonies in semi-solid matrices were examined. Using cord blood mononuclear cells as the source of haematopoietic progenitors, two types of colonies, megakaryocyte colony-forming units (CFU-Meg) and non-CFU-Meg colonies, were established. The former colonies were identified by the presence of cells with translucent cytoplasm and highly refractile cell membrane, most of which were positive for the CD41 antigen. Although the plating efficiency of both types was much higher under serum-containing conditions than under serum-free conditions, the proportion of CFU-Meg to non-CFU-Meg colonies was consistently higher under serum-free conditions. The plating efficiency of CFU-Meg colonies was doubled by adding stem cell factor to the serum-free matrix. The effects of two variants of HHV-6 (HHV-6A and 6B) and human herpesvirus-7 (HHV-7) on TPO-inducible colonies were then compared. HHV-6B inhibited both CFU-Meg and non-CFU-Meg colony formation under serum-free and serum-containing conditions. HHV-6A had similar inhibitory effects. In contrast, HHV-7 had no effect on TPO-inducible colony formation. Heat-inactivation and ultra-filtration of the virus sample completely abolished the suppressive effect. After infection of CD34(+) cells with HHV-6, the viral genome was consistently detected by in situ hybridization. These data suggest that the direct effect of HHV-6 on haematopoietic progenitors is one of the major causes of the suppression of thrombopoiesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675403     DOI: 10.1099/0022-1317-81-3-663

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

Review 1.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

2.  Autoimmune neutropenia of infancy with multiple brain abscesses during the course of human herpesvirus-6 infection.

Authors:  Miyoko Tokushima-Imayoshi; Tomoko Onoue; Muneaki Matsuo; Nobuyuki Yoshida; Takashi Sato; Masao Kobayashi; Yuhei Hamasaki; Eiichi Ishii
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

3.  Human Herpesvirus 6 DNAemia Is Associated With Worse Survival After Ex Vivo T-Cell-Depleted Hematopoietic Cell Transplant.

Authors:  Yeon Joo Lee; Yiqi Su; Christina Cho; Roni Tamari; Miguel-Angel Perales; Ann A Jakubowski; Genovefa A Papanicolaou
Journal:  J Infect Dis       Date:  2022-02-01       Impact factor: 7.759

Review 4.  Platelets and viruses: an ambivalent relationship.

Authors:  Claire Flaujac; Siham Boukour; Elisabeth Cramer-Bordé
Journal:  Cell Mol Life Sci       Date:  2009-12-12       Impact factor: 9.261

Review 5.  Hematopoietic stem cells and retroviral infection.

Authors:  Prabal Banerjee; Lindsey Crawford; Elizabeth Samuelson; Gerold Feuer
Journal:  Retrovirology       Date:  2010-02-04       Impact factor: 4.602

6.  KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo.

Authors:  William Wu; Jeffrey Vieira; Nancy Fiore; Prabal Banerjee; Michelle Sieburg; Rosemary Rochford; William Harrington; Gerold Feuer
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

7.  Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.

Authors:  Lorenzo Dagna; Joshua C Pritchett; Paolo Lusso
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

Review 8.  Human herpesvirus 6 and human herpesvirus 7: emerging pathogens in transplant patients.

Authors:  Duncan A Clark
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.319

Review 9.  The role of platelets in the pathogenesis of viral hemorrhagic fevers.

Authors:  Juan C Zapata; Dermot Cox; Maria S Salvato
Journal:  PLoS Negl Trop Dis       Date:  2014-06-12

10.  Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

Authors:  Najla El Jurdi; John Rogosheske; Todd DeFor; Nelli Bejanyan; Mukta Arora; Veronika Bachanova; Brian Betts; Fiona He; Shernan Holtan; Murali Janakiram; Samantha Larson; Joseph Maakaron; Armin Rashidi; Erica Warlick; John E Wagner; Jo-Anne H Young; Daniel Weisdorf; Claudio G Brunstein
Journal:  Transplant Cell Ther       Date:  2020-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.